MAY 20, 2014 12:00 AM PDT

Oldest Woman on Earth Helps Reveal the Secrets of Life and Death

WRITTEN BY: Peter Micheli
When Hendrikie van Andel-Schipper died in 2005 at the age of 115 she was the oldest person in the world. A research team, led by Henne Holstege of the VU University Medical Center in Amsterdam studied her blood and tissues in an effort to understand the reasons for her longevity. The study results, published in the journal Genome Research seem to indicate our lifespan is limited, curtailed by our cells' finite ability to divide.

We're born with up to 20,000 blood-producing hematopoietic cells. These renew themselves every 25 to 50 weeks by dividing and creating two daughter cells. The cells differentiate to generate various types of blood cells. About 1,300 of these are dedicated to producing new white blood cells in the bone marrow. But, although Andel-Schipper was very healthy right up to the time of her death -- her cognition was clear and her circulatory system was disease-free - most of her white blood cells originated from just two stem cells. So, in theory although Andel-Schipper's general physical and mental health could have allowed her to live for many more years, her lifespan was limited by the cells' ability to divide. Cell division could not go on forever and her body eventually could not keep on regenerating tissues and cells, such as blood.

This raises a question. "Is there a limit to the number of stem cell divisions, and does that imply that there's a limit to human life?" asks Henne Holstege of the VU University Medical Center in Amsterdam, the Netherlands, who headed the research team. "Or can you get round that by replenishment with cells saved from earlier in your life?" she says.

More evidence for the stem cell fatigue came from observing that van Andel-Schipper's white blood cells had drastically worn-down telomeres - the protective tips on chromosomes that shorten each time a cell divides.

The study results raise the science-fiction like possibility of rejuvenating ageing bodies with injections of stem cells saved from birth or early life. These cells would be substantially free of mutations and have full-length telomeres. "If I took a sample now and gave it back to myself when I'm older, I would have long telomeres again - although it might only be possible with blood, not other tissues," Holstege says.

In fact, an experiment by a team led by Amy Wagers of the Harvard Stem Cell Institute in Boston showed that the blood of young mice seemed to rejuvenate ageing blood stem cells in the bone cells of older mice.

In studying Andel-Schipper's blood, researchers also found more than 400 mutations in her white blood cells, but these did not cause disease or otherwise adversely affect her. These mutations, called somatic mutations, because they are not passed along to offspring, were tolerated by her body. The absence of disease and cancer suggest that Andel-Schipper had a better than average capability for repairing or aborting cells with dangerous mutations. Holstege hopes to find clues in genes that protect against cognitive diseases, such as Alzheimer's by comparing Andel-Schipper's DNA to that of much younger people who die of the disease.
About the Author
You May Also Like
SEP 29, 2022
Cell & Molecular Biology
What's In a Lysosome?
SEP 29, 2022
What's In a Lysosome?
The lysosome is a small membrane bound organelle that can be found in most animal cells. It was once thought that these ...
OCT 17, 2022
Microbiology
Is it pan-resistant Candida auris? Now you can know for sure
OCT 17, 2022
Is it pan-resistant Candida auris? Now you can know for sure
Candida auris is a global concern, categorized by the CDC as an Urgent Threat level. According to the CDC's latest 2 ...
OCT 17, 2022
Cell & Molecular Biology
Some Highly Repetitive Protein Sequences are Shared by Many Species
OCT 17, 2022
Some Highly Repetitive Protein Sequences are Shared by Many Species
Gene sequences are made up of nucleotide bases, which are 'read' by the cell's machinery in triplets; three ...
NOV 06, 2022
Genetics & Genomics
The Lone Participant in a CRISPR Therapy Trial has Died
NOV 06, 2022
The Lone Participant in a CRISPR Therapy Trial has Died
In August of this year, a single patient was enrolled in a trial that used CRISPR to correct a genetic mutation that led ...
NOV 17, 2022
Neuroscience
Fluorescent Proteins Extend Blood Flow Tracking to Months in Mice
NOV 17, 2022
Fluorescent Proteins Extend Blood Flow Tracking to Months in Mice
Harmless, fluorescent proteins allow scientists to track blood flow in mice. The advance could help researchers monitor ...
NOV 29, 2022
Genetics & Genomics
Eliminating 'Toxic' RNA Molecules to Treat ALS & Dementia
NOV 29, 2022
Eliminating 'Toxic' RNA Molecules to Treat ALS & Dementia
Researchers have developed a way to target RNA molecules that can have a harmful result. Instead of targeting the genome ...
Loading Comments...